Top 10 Companies in the Taiwan Diclofenac Sodium Market | Competitive Landscape 2026

Taiwan Diclofenac Sodium Market Overview

According to 6Wresearch, the market for Diclofenac Sodium in Taiwan is undergoing steady expansion, on account of the growing geriatric population and the high prevalence of osteoarthritis and musculoskeletal disorders. Diclofenac Sodium is a potent NSAID used to manage pain, swelling, and joint stiffness.

The market is driven by the demand for various delivery formats, including oral tablets, topical gels, and injectable solutions. In addition, the government's stringent quality control standards and the expansion of the National Health Insurance system have made these vital pain management therapies more accessible to the public.

Competitive Landscape

The competitive landscape of the Taiwan Diclofenac Sodium industry is curated of several domestic brands and global manufacturers, that are dominating the market through specialized delivery systems and cost-effective generic formulations. The leading position of these brands is sustained through continuous investment in R&D to minimize the side effects and improve their pain management portfolios.

Below is a list of leading players operating in the Taiwan Diclofenac Sodium Market:

1. Yung Shin Pharmaceutical Ind. Co., Ltd.

Yung Shin is a major player offering various NSAID formulations, leveraging a massive domestic distribution network.

2. Sinphar Pharmaceutical Co., Ltd.

Sinphar is well-known for its diversified portfolio of ethical drugs focusing on pain management and skin-care therapeutics.

3. Standard Chem & Pharm Co., Ltd.

Standard produces high-quality generic diclofenac products that are staples in Taiwan's hospitals.

4. TTY Biopharm Company Limited

TTY is recognized for its advanced drug delivery technologies, including sustained-release formulations of anti-inflammatory drugs.

5. China Chemical & Pharmaceutical Co., Ltd. (CCPC)

CCPC is a leader in the domestic NSAID market, providing a wide array of treatments for chronic inflammatory conditions.

6. Oriental Chemical Works Inc.

Oriental Chemical Works specializes in hospital-grade injectables and essential medicines, including pain relief solutions.

7. Astar Chemical & Pharml Co., Ltd.

Astar remains a dominant force in the ethical drug market, catering to a large patient base requiring long-term orthopaedic care.

8. Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB)

CCSB focuses on various therapeutic areas, providing reliable anti-inflammatory drugs through its robust manufacturing facilities.

9. Purzer Pharmaceutical Co., Ltd.

Purzer is highly regarded for its specialized analgesics and its commitment to producing high-purity pharmaceutical ingredients.

10. Synmosa Biopharma Corporation

Synmosa maintains a strong presence through its expertise in respiratory and musculoskeletal pain treatments.